Yeah and if you watched their last meeting they ar
Post# of 148165
(Total Views: 447)
Posted On: 09/24/2021 10:00:13 AM
Yeah and if you watched their last meeting they are betting the whole farm on Dr Patentson and first revenue on a EUA for Long Haulers with revenue expected in July of 2022.
There is two things wrong with this prediction or future direction…
1) There will be no unmet medical need for Long Haulers so a EUA will not apply and we will have to seek a full BLA. The time needed for a BLA if everything was quick would be over a year. Not 8-9 months.
2) What does this mean about the coveted Brazil trials. Are they aware we have trials open and enrolling in Brazil? Yes they are but somehow they said that they don’t feel Brazil will make us any money and we will sell below cost and lose money. They said this in their meeting. It blew me away. They also said that it wasn’t worth even doing the trials because Brazil only represent 10% of the drug sales world wide. What a stupid comment. Let’s do some math.
Say we sold all 700,000 doses we promised Biomm. Say we sold them for half the USA price of $1500 or $750/2 because of the split with Biomm. This equals $375 dollars each. The cost of our last small batch of Leronlimab cost was $75/dose. $375-$75 cost = $300 a dose. Then multiply that by 700,000 doses x $300/dose = $210,000,000.
Do we stop this trial? Leave 210 million dollars on the table and walk away? Is this what they will do to us? Closetinvestor always said that they would only trial one indication at a time. Stop all trials and focus on the HIV BLA. Now they changed priorities and changed to Long Haulers for their first revenue.
What this sounds like to me is to purposely bankrupt our company if they were to take control. This group doesn’t know how to initiate priorities and prioritize what we have going on. Why would we cancel all trials to focus on one trial when our first approval could pay for everything. This groups seems lost and priorities are not aligned with what is currently happening. They don’t have enough sense to complete the trials we have started. This is amazing how stupid they look.
There is two things wrong with this prediction or future direction…
1) There will be no unmet medical need for Long Haulers so a EUA will not apply and we will have to seek a full BLA. The time needed for a BLA if everything was quick would be over a year. Not 8-9 months.
2) What does this mean about the coveted Brazil trials. Are they aware we have trials open and enrolling in Brazil? Yes they are but somehow they said that they don’t feel Brazil will make us any money and we will sell below cost and lose money. They said this in their meeting. It blew me away. They also said that it wasn’t worth even doing the trials because Brazil only represent 10% of the drug sales world wide. What a stupid comment. Let’s do some math.
Say we sold all 700,000 doses we promised Biomm. Say we sold them for half the USA price of $1500 or $750/2 because of the split with Biomm. This equals $375 dollars each. The cost of our last small batch of Leronlimab cost was $75/dose. $375-$75 cost = $300 a dose. Then multiply that by 700,000 doses x $300/dose = $210,000,000.
Do we stop this trial? Leave 210 million dollars on the table and walk away? Is this what they will do to us? Closetinvestor always said that they would only trial one indication at a time. Stop all trials and focus on the HIV BLA. Now they changed priorities and changed to Long Haulers for their first revenue.
What this sounds like to me is to purposely bankrupt our company if they were to take control. This group doesn’t know how to initiate priorities and prioritize what we have going on. Why would we cancel all trials to focus on one trial when our first approval could pay for everything. This groups seems lost and priorities are not aligned with what is currently happening. They don’t have enough sense to complete the trials we have started. This is amazing how stupid they look.
(17)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼